In the BioHarmony Drug Report Database
Danaparoid
Orgaran (danaparoid sodium) is an unknown pharmaceutical. Danaparoid sodium was first approved as Orgaran on 1996-12-24. It is used to treat pulmonary embolism, thrombocytopenia, thromboembolism, and venous thrombosis in the USA. The pharmaceutical is active against antithrombin-III.
Trade Name
|
Orgaran |
|---|---|
Common Name
|
danaparoid sodium |
ChEMBL ID
|
CHEMBL1201534 |
Indication
|
pulmonary embolism, thrombocytopenia, thromboembolism, venous thrombosis |
Drug Class
|
Antithrombotics (heparinoid type) |
Image (chem structure or protein)
